Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc®
4/16/2014 9:23:07 AM
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today announced the first U.S. commercial sale of Monovisc® by its commercial partner, DePuy Synthes Mitek Sports Medicine*, a leading orthopedic sports medicine company.
Help employers find you! Check out all the jobs and post your resume.
comments powered by